Identification of predictive factors for post-transarterial chemoembolization liver failure in hepatocellular carcinoma patients: A retrospective study

doi:10.12998/wjcc.v10.i24.8535

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 24

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3135)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

146

WORD

HTML

1636

Figures (1-3)

283

Tables (1-2)

199

Sum=2326

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

245

Download

564

Sum=809

Aug 26, 2022 (publication date) through Aug 25, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Aug 26, 2022; 10(24): 8535-8546
Published online Aug 26, 2022. doi: 10.12998/wjcc.v10.i24.8535

Full Size Figure Download Figure

Figure 1 Nomogram for probability of post-transarterial chemoembolization liver failure in hepatocellular carcinoma patients. A: The nomogram model; B: The calibration curve of the nomogram model with internal validation through bootstrapping. TACE: Transarterial chemoembolization.

Citation: Yuan M, Chen TY, Chen XR, Lu YF, Shi J, Zhang WS, Ye C, Tang BZ, Yang ZG. Identification of predictive factors for post-transarterial chemoembolization liver failure in hepatocellular carcinoma patients: A retrospective study. World J Clin Cases 2022; 10(24): 8535-8546
URL: https://www.wjgnet.com/2307-8960/full/v10/i24/8535.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i24.8535